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1. Introduction 
VATS lobectomy and other major pulmonary resections (VMPR) are growing in popularity. 
One of the main criticisms against minimal access in lung cancer surgery is that mediastinal 
nodes could be difficult to assess. It was shown by different authorities that VATS complete 
nodal dissection is feasible and does not differ from that performed by an open thoracotomy 
[1]. Despite conflicting reports, there is an international agreement that nodal dissection 
does not influence the disease free or the overall survival in lung cancer. However; proper 
staging of Non Small Cell Lung Cancer (NSCLC) enables standardization of decision on 
treatment and evaluation of such treatment comparing it to different centres around the 
world. Recent publications have shown a significant statistical gain in 5 year survival if 
stage IIa and higher were treated by adjuvant chemotherapy [2, 3]. It is therefore absolutely 
mandatory to get the staging right in early lung cancer; otherwise patients would be denied 
a significant chance of cure. In a pressurised service where commissioning is governed by 
patients waiting times, targets and cost effectiveness, surgeons might feel reluctant to extend 
the operating time to perform Systematic Nodal Dissection (SND). The risk of improper 
mediastinal staging in our view is by far greater than extending the duration of the 
operation. The long-term results of stage migration lead to faulty comparison, and might 
dictate the wrong management, ending in completely erroneous survival statistics. 
Oncological randomised controlled trials rely on final histological staging, and therefore it is 
mandatory to obtain correct staging to avoid erroneous survival statistics in such trials. In 
our view the only contraindication to SND would be technical difficulty with dissection in 
the presence of severe adhesions 
The way we stage lung cancer has changed over the years. The TNM6 classification [4] is 
now superseded by the IASLC new TNM7 classification [5]. Fortunately the naming and 
significance of nodal stations has not changed substantially. Precarinal nodes #3 for a left 
sided tumour is now considered an N3 stage. Precarinal nodes for a right sided tumour are 
designated as #4 (there are no #3R), and these are regarded as N2 disease.  
2. Definitions 
There are different protocols for staging the mediastinum in search of metastasis in N2 
nodes. These include: 
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• Selective node sampling: the surgeon decides which node looked diseased and 
randomly removes that node (chance node). 
• Sentinel nodal sampling: at operation the primary tumour is injected with 99Technitium 
tracer, and a Geiger counter is used to identify the sentinel hilar nodes which are 
dissected. If frozen section confirmed absence of metastases, the rest of nodal dissection 
is omitted (decision node). 
• Systematic nodal sampling: one or two nodes sampled from each zonal station 
(selective). 
• Systematic Nodal dissection: at least 2 nodes from each field or station, and at least 3 
fields are dissected (total of at least 6 nodes). Must always include subcarinal nodes 
(universally accepted) [6]. 
• Lobe-specific nodal sampling: oriented towards the different lymphatic drainage of 
different lobes e.g. for a right upper lobe tumour, the fields to harvest would be #2-4. 
Subcarinal lymphadenectomy is not always necessary for tumours of the right upper 
lobe and left upper trisegmentectomy (selective) [7]. 
• Extended nodal dissection: by definition means bilateral dissection of nodes (no 
consensus on extent). 
Each of these protocols has points of strengths as well as weaknesses. In general the more 
the number of harvested nodes, the more likely it is to reveal normal looking nodes with 
metastatic tumour cells.  
• Skip metastases: when stations N2 are involved in the absence of N1 involvement, or 
N3 involvement in the absence of either N1-N2 nodes. The importance of this 
phenomenon is not fully understood [8]. 
• Micrometastases: The prognosis of cancer patients is largely determined by the 
occurrence of distant metastases. The presence of clinically occult few malignant cells 
within nodal tissue, bone marrow and pleural fluid, and the clinical relevance of 
circulating tumour cells are still debatable. The importance of such nodal involvement 
is not fully understood, as it does not inevitably lead to disease dissemination and 
disease progression [9, 10]. 
3. Invasive v non-invasive staging 
The tools of staging the mediastinum in NSCLC are either invasive in nature such that 
histological confirmation of nodal involvement is sought, or non-invasive, whereby an 
imaging technique is used to infer involvement of nodes by secondary metastasis. Invasive 
procedures such as mediastinoscopy, mediastinotomy, EBUS-TBNA (Endo Bronchial Ultra 
Sound - Trans Bronchial Fine Needle Aspirate) and EUS (Endoscopic or trans oesophageal 
Ultra Sound guided Trucut biopsy or FNA) are still developing. These investigations have 
limitations in terms of tissue yield, safety profile and cost. At best these are sampling 
techniques, aimed at sampling specific nodes which have been highlighted by other non-
invasive techniques. None of these procedures can claim radical dissection of mediastinal 
nodes. However, recently VAMLA (Video Assisted Mediastinal Lymph Adenectomy) [11] 
has claimed bilateral mediastinal clearance of nodes, yet there are still issues with reaching 
stations #5L & #6L [figure 1] and the distant stations #8 & #9. To enhance the yield of nodes 
VATS was added to VAMLA to achieve radicality of nodal dissection [12]. On the other 
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hand TEMLA (Transcervical Extended Mediastinal Lymph Adenectomy) was introduced in 
2004, which involved a collar incision in the neck, elevation of the sternal manubrium with a 
special retractor, and claims bilateral dissection of all mediastinal nodes apart from #8 & #9 
[13]. The choice of using any of the above mentioned techniques depends on the philosophy 
of nodal sampling versus radical adenectomy. 
Non-invasive preoperative techniques have largely concentrated on CT and PET. Whilst 
Computed Tomography (CT) can give great anatomical details of the mediastinum and 
other chest anatomy, it cannot differentiate benign from malignant tissue. Positron Emission 
Tomography (PET) on the other hand was claimed to make that biological distinction.  
 
Fig. 1. Station #5L node out of reach of the mediastinoscope (blue circle). 
4. The Role of PET 
Great hopes were pinned on PET as it seemed to be the most convenient non-invasive 
staging tool for a fast tract keyhole surgery such as VMPR designed for early lung cancer. 
PET was expected to identify nodal disease in CT negative and normal looking 
mediastinum. Recent meta analysis reporting the PET/CT mediastinal staging in patients 
with NSCLC found the median sensitivity to be 85% (range 67% to 91%) and specificity of 
90% (range 82% to 96%) [14]. Gilles et al and Plathow et al summarised the current views 
about the elevated glucose metabolism in cancers [15,16]. Tumour cells adapt to hypoxia by 
upregulation of glucose Transporter (GLUTs) and increased activity of Hexokinase. The 
GLUT is the first energy-independent glucose transporter across the cell membrane down 
the concentration gradient. Tumours increase their level of energy production by engaging 
in glycolysis, which is a relatively inefficient way to produce energy compared to aerobic 
oxidation (2 ATP molecules versus 30 ATPs). The toxic acidic tumour microenvironment 
results in death of normal tissue while tumour cells evade apoptosis by maintaining normal 
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intracellular pH. It is thought that this process give the tumour cells a competitive 
advantage for local growth, ultimately leading to invasion of basement membrane and 
distant metastases. Primary tumours and their nodal secondaries express high GLUT1 
upregulation, which in turn is tied to 18F-FDG accumulation in the tumour cell, and hence 
directly related to SUVmax (Maximum Standard Uptake Value). GLUT expression is tied to 
tumour cell type and differentiation. Squamous cell carcinoma exhibit over expression of 
GLUT1 whereas adenocarcinoma does not. One of the serious disappointments of PET 
scanning in lung cancer is the low uptake of carcinoids, adenocarcinoma and 
bronchioloalveolar carcinomas, in some series up to 40%. This tumour biological behaviour 
explains why PET is blinded to adenocarcinoma, Bronchiolo-alveolar carcinoma (BAC) and 
carcinoids tumours. For the same reason the importance of the SUVmax (>3.5) as a surrogate 
value for malignancy has been played down. Another important snag about the uptake of 
the FDG metabolite is the mass of active tissue. A node under 1cm in diameter is unlikely to 
show up as a hot spot on PET even if it was completely replaced by secondary malignant 
tissue. Al-Sarraf et al found that integrated CT/PET images had reduced sensitivity for non-
enlarged <1cm nodes (40%) [17]. Clinicians should be aware of this fact when interpreting 
the results, and histological confirmation should be sought on CT positive (>1.0cm in its 
shortest diameter) or PET positive nodes. The international literature seems to suggest that 
the rate of unexpected (occult) N2 disease in c-N0-1 to be 10%. It is likely that the role of PET 
will continue to evolve with further clinical studies using other new tracers such as the 
thymidine analogue 3'-deoxy-3'-[18F]fluorothymidine, which more specifically targets 
proliferative activity of malignant lesions and can differentiate them from the false-positive 
inflammatory lesions, as seen with FDG [18]. It should not be forgotten that one of the very 
useful functions of routinely performed PET in early lung cancer is to exclude obvious 
metastases to liver, adrenal, bone etc that would have otherwise precluded curative 
resection [figure 2]. 
 
Fig. 2. CT/PET of a patient with right upper lobe lesion. Bronchoscopy obtained squamous 
cells carcinoma. The high intake of 18FDG seen in precarinal node #4R was sufficient 
evidence not to proceed with mediastinoscopy. The patient was treated by chemo-
Radiotherapy. 
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5. Preoperative v postoperative staging  
The significance of preoperative as opposed to postoperative staging in resectable early lung 
cancer is tied to what the clinician wants to do with the information. There might be little 
disagreement about the N1 disease, but controversy surrounds N2 disease. In our opinion 
For a CT negative and PET negative mediastinum, no further investigation is needed, and 
patients should proceed to resectional operation + SND. Further multidisciplinary 
management should be based on SND staging. This is in line with the latest published 
British Thoracic Society (BTS) guidelines [19]. The dilemma arises when there is histological 
evidence of single station N2 disease preoperatively. The choices being (1) avoid surgery all 
together and opt for chemo-radiotherapy (2) induce chemotherapy before surgery, or (3) 
make a run for surgery while the tumour is operable and follow that by adjuvant 
chemotherapy / radiotherapy. The first approach is advocated by Albain et al (2009) who 
showed that lobectomy will add little to Chemo-radiotherapy for patients with stage IIIa 
(N2) non-small-cell lung cancer, at the expense of higher mortality (evidence level 1b) [20]. 
The second approach is supported by the S9900 trial follow up published in 2010 which 
continues to show that the best treatment for N2 resectable lung cancer would be induction 
chemotherapy followed by surgery (evidence level 1b) [21]. Rocco et al (2010) is supportive 
of the third approach, concluding that standard treatment of initially resectable stage IIIa 
NSCLC remains surgery followed by adjuvant chemotherapy (evidence level 2a) [22]. The 
subject remains controversial, and patients should be involved in decision taking. Surgery is 
known to give local control and reduce local recurrence, whereas chemotherapy is a 
systemic treatment designed to reduce disease progression and distant metastases. 
Currently we rely on CT/PET, mediastinoscopy or EBUS to direct the patient to one form of 
treatment or prevent unnecessary operation. However, Lim et al conducted a systematic 
review of all the published meta-analysis of randomised trials in preoperative versus 
postoperative chemotherapy in patients with resectable lung cancer (evidence level 1a) [23]. 
They concluded that in patients with resectable lung cancer, there was no difference in 
overall and disease-free survival between the timing of administration of chemotherapy 
(postoperative versus preoperative). Clearly this sends a strong message that earnest 
preoperative investigation of the mediastinum in PET negative resectable early lung cancer 
might be unnecessary. Myers et al specifically considered the cost effectiveness of routine 
mediastinoscopy in CT-negative, PET-negative patients with stage I lung cancer [24]. They 
concluded that routine mediastinoscopy would add an average 0.01 years (3.65 days) of life 
at a cost of $201,918 per life-year gained. Therefore they do not recommend routine 
mediastinoscopy in PET-negative patients. Our practice advocates neoadjuvant 
chemotherapy followed by surgical VMPR-SND followed by adjuvant chemotherapy based 
on proper SND staging, provided nodal involvement remains single station or single zonal. 
Multizonal involvement is best served by chemo-radiotherapy, as it is regarded as systemic 
disease. Surgery alone will not have an impact on the 5 years survival, but might have a 
palliative effect on local recurrence, and might be considered for instance to control 
haemoptysis, or continued sepsis precluding the start of other modalities of treatment such 
as chemotherapy.  
6. Where are these mediastinal nodes? 
Although nodal mapping has been there for a long time, it seems that there is considerable 
discordance in nomenclature and designation of nodal stations between Asian and European 
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thoracic surgeons [25]. Historically the Naruke map was the most popular and most followed 
worldwide until recently [26]. The American Thoracic Society introduced the Mountain-
Dressler ATS map in 2007, and finally Rusch et al from the Memorial Sloan-Kettering Cancer 
Centre introduced the current IASLC nodal map (International Association for the Study of 
Lung Cancer 2009) to achieve uniformity and to promote analyses of a planned prospective 
international database [27]. The IASLC map reconciles differences among other used maps, 
and provides precise anatomic definitions for all lymph node stations. A method of grouping 
lymph node stations together into "zones" is also proposed for the purposes of future survival 
analyses [Figure 3]. It goes without saying that surgeons should familiarise themselves with 
the details of this map to standardise the staging process in any given centre. 
 
Fig. 3. The IASLC 2009 Nodal map. 
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7. VATS-SND: Can it be comprehensive? 
One of the major criticisms against VATS lung cancer resection is that it is not an 
oncologically feasible operation, as assessment of the mediastinal nodes is not as complete 
as open thoracotomy. Comprehensive radical nodal dissection is possible by VATS and 
should not be different to open thoracotomy, as described by Watanabe et al [1]. The 
number of harvested nodes is an accepted surrogate to completeness of SND. 99% of 
patients should have 6 or more nodes harvested from 3 stations as reported in the ACOSOG 
Z0030 Trial [28]. Racial variations might play a role in the total number of nodes harvested. 
Video-assisted surgical approach should not adversely affect the yield of lymph node 
harvest, however; despite extreme care it is sometimes unavoidable to fragment nodes 
during harvesting [29]. There are few published studies that attest to completeness of VATS-
SND, but the most impressive was that of Sagawa et al [30]. After VATS lobectomy-SND, a 
standard thoracotomy was subsequently opened by a different surgeon to complete 
systematic nodal dissection and revisit the VATS-SND dissection. The average addition to 
VATS-SND was 1.2 nodes only. The remnant ("missed" by VATS) lymph nodes and tissues 
were 2-3%, which seems acceptable for clinical stage I lung cancer. No nodal involvement 
was observed in the remnant lymph nodes. It would be difficult to obtain clearance for such 
a study in Europe, but its results are resounding assurance that with practice, VATS SND 
should be identical to open SND. 
8. VATS-SND: How to do it 
VMPR is usually considered for early lung cancer T1-2, N0-1 and M0. The decision to 
include these patients in the VATS series is based on CT/PET studies. The procedure is 
performed under general anaesthesia, utilising single lung ventilation. 3 ports are fashioned, 
2X1cm and a utility port 3-4cm long at the mid-axillary line over the 4th or 5th intercostal 
space. Nodal harvesting can be performed before, during or after the VATS resection 
(lobectomy, pneumonectomy, segmentectomy etc) according to published European and 
international standards [6, 26,28,31].  
 
 
 
We harvest nodes en-block, stations 2-4,7,8,9,10 and 11 on the right, preserving the Azygos 
vein, and 4,5-6,7,8,9,10, 11 on the left side, preserving the ligamentum arteriosum [32]. We 
SND criteria:  
• At least 3 fields nodal dissection  
• At least 2 nodes from each field 
• Subcarinal #7 always included 
 
Southampton “Motto”:  
• Every visible node!  
• “if you see a node, it should be in a pot..” 
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do not harvest #1 bilaterally, or #2 on the left. However, we harvest #3 (precarinal) when 
indicated on the left chest without dividing the ligamentum arteriosum by retracting the 
main pulmonary artery up and pushing the carina down1. Subcarinal nodes #7 were 
mandatory for the definition of SND, and if these were not harvested the procedure would 
have been classified as ‘Nodal sampling’ and not SND [6]. The procedure extends the 
operative time by 30 minutes on the right chest and between 45-60 minutes on the left chest. 
VATS-SND during VMPR requires patience. Whereas en block dissection on the right is 
straight forward, that on the left is more taxing. Subcarinal #7 on the left is the most time 
consuming, as the space has to be clearly displayed. We routinely access it from the back of 
the hilum, starting with SND before resecting the lung. We found great variation in the 
number and consistency of nodal groups, especially #8 and #9. Nodes could be completely 
absent, discrete or lumped in a fibro-fatty tissue amenable to block dissection. 
Right side: 
Planning the port sites is an important part of nodal dissection, and if the ports are set too low 
the dissection will be a struggle. The anterior utility port should not be lower than the 5th 
space, and preferably on the 4th space. The posterior port is fashioned over the auscultatory 
triangle 1-2 finger breadths from the medial border of the scapula. The inferior port is created 
opposite the highest point in the dome of the diaphragm, in line with the hilar axis [Fig. 4].  
 
Fig. 4. The camera scope is inserted from the inferior port, and remains there. 
                                                                 
1 Amer K (2011). Routine Systematic Mediastinal Nodal Dissection During VATS Major Pulmonary 
Resections—The Southampton Technique. Available 
http://www.ctsnet.org/sections/videosection/videos/vg2011_AmerK_SystematicMediastinal.html. 
last accessed 01.04.2011 
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SND is started by releasing the inferior pulmonary ligament, and exposing the inferior 
pulmonary vein, bringing #9 nodes into light [Fig. 5].  
 
Fig. 5. Releasing the inferior ligament. 
The pleural reflection between the SVC and the oesophagus is opened down to the 
diaphragm, exposing #8 para-oesophageal nodes. The number and consistency of nodes in 
#8-9 vary greatly. Our method of dissection has evolved into using a malleable diathermy 
spatula which is insulated albeit for the last 1-2 mm, whilst keeping the energy level at low. 
Diathermy dissection reduces bleeding and chyle leak, and keeps the operative field neat. 
Dissection of #8-9 nodes is usually straight forward [Fig. 6-7]. 
 
Fig. 6. En-block dissection of #8. 
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Fig. 7. Schematic location of #8 & #9. 
The subcarinal nodes on the right side are found between the right main bronchus and the 
oesophagus. The lung is retracted anteriorly and the pleural reflection at the back of the 
hilum is opened from the inferior ligament to the concavity of the Azygos vein, medial to 
the vagus nerve. All vagal bronchial branches could be cut with impunity [Fig. 8-10].  
 
 
 
Fig. 8. Vagal bronchial twigs. 
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Fig. 9. Schematic location of #7. 
 
Fig. 10. The thoracic duct surface anatomy. 
The right main bronchus is identified and followed proximally until the left main bronchus 
is seen and identified. The subcarinal nodes are dissected off their blood supply, and for 
convenience of retrieval a Polythene bag could be used. This is not always necessary. 
Careful labelling of nodes is to be practiced here as para-oesophageal #8 and para-bronchial 
#10 nodes could easily be mistaken as #7. Care must be taken not to dig holes in the 
membranous part of the bronchus or the delicate oesophagus. One should not worry much 
about thoracic duct injury in this location, as the duct is tucked away from harm’s way by 
the oesophagus [Fig. 10]. At the end of this dissection the right main bronchus, the left main 
bronchus and the subcarinal space should be well on display [Fig. 11]. 
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Fig. 11. The right subcarinal space. 
Dissection of the parabronchial nodes #2-4 lies within the superior triangle. This triangle is 
bound by the Vagus and Phrenic nerves, and based on the Azygos vein [Fig. 12].  
  
Fig. 12. The right superior triangle. 
The pleura is opened like a trap door, just lateral to the SVC and just above the Azygos vein 
[Fig. 13]. The Vagus nerve sould be found plastered to the inside flap of the pleura. 
Retraction of the pleura using a Prolene stitch opens the triangle and helps in dissection 
[Fig. 14].  
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Fig. 13. Trap door to #2-4. 
 
 
Fig. 14. Retraction of Vagus nerve. 
Station #2-4 nodes in the para and pre-tracheal groups exist in a fibro-fatty block that could 
be dissected en block most of the times. Low energy diathermy is used as before. The 
dissection is started by pushing the SVC away from the block. One should be aware of the 
existence of at least one constant vein draining directly from the block to the SVC [Fig. 15]. 
These veins should be controlled by metal ligaclips or ultrasonic device before proceeding. If 
they are accidently cut they have the propensity to retract and disappear, making control of 
the bleeding difficult. 
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Fig. 15. Direct draining vein from block to SVC.   
Further deeper dissection high in the triangle between the SVC and the block identifies the 
main stem trachea [Fig. 16]. Once the apex of the block is brought down, the dissection 
becomes easier.  
 
Fig. 16. Identifying the main stem trachea. 
Next the lateral part of the block is separated from the vagus nerve. The block is then lifted 
off the tracheal, and the retrocaval part is freed. Large lymphatic channels could be seen 
here, and differentiated from nerves by their lobular contour and loss of sheen. Again the 
block is delivered out of the chest in a Polythene bag for convenience of retrieval only [Fig. 
17]. Small discrete nodes are retrieved directly on a surgical instrument.  
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Fig. 17. Retrieval in a Polythene bag of #2-4. 
The bed of the superior triangle is made of the arch of the aorta and the right 
bracheocephalic artery and the main stem trachea [Fig. 18]. The recurrent laryngeal nerve 
descends into the thoracic inlet parallel to the vagus on the lateral side of the carotid artery. 
It makes a quick exit out of the chest as it loops around the origin of the right subclavian 
artery, soon after it enters the thoracic inlet. It continues its course cephalad towards the 
trachea-oesophageal groove in the neck. This point of looping is approximately 1 cm from 
the aortic arch, and corresponds to the length of the brachiochephalic trunk [Fig. 18]. It lies 
at the apex of the superior triangle, and diathermy should be used with extreme caution in 
this area, especially when the highest #2 nodes are attempted.  
 
Fig. 18. Location of the right recurrent laryngeal nerve. 
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Again enthusiasm should be curbed not to cross the median line into the left side, as injury 
to the thoracic duct could occur. By the end of this dissection the whole length of the trachea 
should be seen bare of nodes, including a clear retrocaval and retro-azygos spaces [Fig. 19]. 
 
Fig. 19. The view after clearance of #2-4. 
Left side: 
Dissection is also started here by releasing the inferior pulmonary ligament. This exposes #9 
around the inferior vein [Fig. 20]. The pleural reflection between the pericardium and the 
descending aorta is opened longitudinally from the inferior ligament to the diaphragm. The 
diaphragm and the pericardium might require retraction using a swab on a stick to expose 
this area [Fig. 21].  
 
Fig. 20. Exposing left inferior ligament. 
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Fig. 21. Pleural landmarks for opening #8 &#9. 
 
Fig. 22. En-block dissection of left #8. 
This exposes #8 nodes which again could be absent, discrete or forming a fibro-fatty block. 
Care is taken not to injure the vagus, oesophagus, and other organs which are usually not 
there but could be there, such as a hiatus hernia [Fig. 22].     
Dissection of the subcarinal #7 nodes on the left side is time-consuming, and require a 
prepared plan of action, good suction and detailed mastery of the surrounding anatomy. On 
retracting the lung anteriorly two nerves and a vein are noted to cross the arch of the aorta. 
The Phrenic nerve passes anterior to the hilum, whereas the Vagus passes posterior to the 
hilum. The superior intercostal vein draining the upper 3-4 spaces traverses the upper part 
of the aorta, crossing the origins of the left subclavian and carotid arteries and drain straight 
into the innominate vein [Fig. 23].  
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Fig. 23. The hilum watershed between Phrenic and Vagus nerves. 
It will be noted that the left recurrent laryngeal nerve descends separate and parallel to the 
Vagus and hooks around the concavity of the aorta (ligamentum arteriosum) lateral to the 
vagus. We do not go out of our way to dissect and demonstrate its path, but avoid injury to 
the recurrent laryngeal by avoiding disturbing the pleura between the arch of aorta and the 
vagus nerve [Fig. 24]. On the other hand all vagal bronchial branches are cut with impunity 
[Fig. 25]. 
 
 
Fig. 24. The no man’s land of the recurrent laryngeal nerve. 
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Fig. 25. Left vagal bronchial twigs. 
Dissection is started by opening the pleural reflection at the back of the hilum, from the 
inferior ligament, up to and beyond the aortic arch. Dissection is kept lateral to the vagus, 
cutting all vagal bronchial branches. One or two bronchial arteries arising directly from the 
aorta might need to be secured before the space is fully exposed for nodal dissection [Fig. 
26].  
 
 
 
Fig. 26. Vagal bronchial twigs must be cut to access #7. 
www.intechopen.com
 
Topics in Thoracic Surgery 266 
 
 
Fig. 27. Exposing the left subcarinal space. 
The subcarinal nodes lie in a deep layer, not easily appreciated, deeper than the oesophagus, 
which is deeper than the aorta. One could make use of strong retraction on the lower lobe 
bronchus using a tape (has to be sturdy for strong retraction). This will bring the subcarinal 
space forward into view, and improve vision. A vascular sloop could be used around the 
oesophagus and gentle traction applied to assist in opening the space, but this is not 
mandatory [Fig. 27].      
 
 
Fig. 28. #7 node. 
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The principle here is to follow the lower lobe bronchus proximally, as it leads us to the 
subcarinal space. Pinpoint diathermy dissection of the nodes off their blood supply is 
performed, taking care not to dig holes in the membranous part of the bronchus. The right 
main bronchus and the subcarinal space should be well on display by the end of this 
dissection [Fig. 28-29].  
 
 
Fig. 29. Anatomy of the subcarinal space. 
Nodes that are clearly related to the inferior vein, lower lobe bronchus or the main 
pulmonary artery are labelled as #10. However; the most lateral of the aorto-pulmonary 
group are labelled as #4, and these are at a deeper level than #10. 
 
Fig. 30. Exposing pretracheal #3 nodes. 
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The precarinal #3 nodes could be accessed from the left side if required. The plane of 
dissection lies below the pulmonary artery, and hence there is no need to dissect and cut 
the ligamentum arteriosum. The main pulmonary artery is freed from the bronchus and a 
sloop passed around it. The space under the artery is dissected, and explored by pushing 
the carina down and the artery up. This manoeuvre exposed the main stem trachea [Fig. 
30]. Pretracheal nodes are identified and dissected. Minimal use of diathermy is 
recommended in this position, as this is the likely position to injure the recurrent 
laryngeal nerve. 
 
 
Fig. 31. The left superior triangle. 
Dissection of #5 (preaortic) and #6 (sub-aortic and aorto-pulmonary) nodes should be 
attempted en block. These nodes exist in a triangle similar to the right side, bound by the 
vagus and Phrenic nerves and the arch of the aorta [Fig. 31]. The fibro-fatty block is lifted off 
the main pulmonary artery into the aorto-pulmonary space, medial to the vagus nerve. The 
phrenic nerve is identified and slung using a vascular sloop to avoid harming it. The nodal 
block is dissected up to the origin of the left subclavian artery, and the block delivered out of 
the chest.  
9. Complications of SND 
VATS-SND is safe, and does not add to the morbidity or mortality of the originally planned 
operation. However there are some complications the surgeon should be aware of: 
Major complications: 
• Vascular injury; SVC, Aortic arch, Azygos vein etc. 
• Bronchial injury; usually the membranous part of major bronchi, especially dissecting 
around the subcarinal space 
• Recurrent laryngeal nerve injury; on the right the danger arises when diathermy is used 
around the origin of the subclavian artery, and on the left when dissecting #3 
(precarinal) at the space between main pulmonary artery and main stem trachea. 
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• Chyle leak; is rare and usually occurs if dissection involved large lymphatic ducts, 
mobilisation of oesophagus or in the presence of abnormal anatomical course of the 
thoracic duct.  
• Port-site seedling, which is rare (0.5%) and seems to happen irrespective of whether the 
nodes were retrieved in a polythene bag or not [32,33]. 
Minor complications: 
• Increased postoperative tube drainage. 
• Irritant cough due to diathermy close to the main bronchi. 
• Temporary odynophagia (painful swallowing) due to mobilisation of the oesophagus. 
10. VATS nodal sampling v dissection 
The current evidence suggests that complete mediastinal lymph node dissection is 
associated with improved survival compared with node sampling in patients with stage I–
IIIa NSCLC undergoing resection [34]. 
11. SND and immune response 
It was reported that Systematic lymphadenectomy added to major lung resection performed 
by open thoracotomy does not increase postoperative humoral immune response in 
uncomplicated cases [35]. However; there are no studies in the literature that looked into the 
VMPR-SND and the role of SND in postoperative inflammatory response.  
12. Conclusion 
VATS Systematic Nodal Dissection during VATS major pulmonary resections is feasible and 
safe. It should be performed routinely even when nodal involvement is unlikely, as 10% of 
patients in clinical stage N0-1 will have N2 disease. Multidisciplinary adjuvant treatment of 
lung cancer should be based on SND staging. 
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